“…13 A fixed-effects model of analysis was adopted in the absence of statistical heterogeneity, whereas a random-effects model was preferred in cases of substantial heterogeneity. Sensitivity analyses were conducted as follows: withdrawing 1 study at a time, withdrawing studies in which preprocedural bridging with low-molecular-weight heparin in the DW group was not required, 6,11,14 withdrawing low-quality studies, 6,8,11,14 and withdrawing the study in which an indirect comparison analysis with the Worldwide Survey population was performed. 2,7 Subgroup analyses were carried out to appraise the impact of baseline patient characteristics (age, sex, average CHADS 2 [congestive heart failure, hypertension, age Ն75 years, diabetes mellitus, prior stroke or TIA] score, type of AF, and left atrial diameter), procedural data and different intraprocedural anticoagulation strategies (ie, use of open-irrigation catheters, ablation techniques, administering unfractionated heparin bolus before or after the transseptal puncture, different heparin doses or target activated clotting times), and of intracardiac echography (ICE) monitoring on periprocedural complications.…”